502 results on '"Chamaillard, Mathias"'
Search Results
2. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
3. Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis
4. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation
5. The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance
6. The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt + Treg and PD-1 blockade efficacy
7. NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome
8. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
9. NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner
10. Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes
11. Loss of NOD2 in macrophages improves colitis and tumorigenesis in a lysozyme-dependent manner
12. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype
13. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
14. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
15. Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis
16. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
17. Gene-Environment Interaction Modulated by Allelic Heterogeneity in Inflammatory Diseases
18. The battlefield in the war against attaching-and-effacing bacterial pathogens: Monocytes, macrophages and dendritic cells in action
19. Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?
20. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
21. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses
22. The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt+ Treg and PD-1 blockade efficacy.
23. NOD2 in monocytes negatively regulates macrophage development through TNFalpha
24. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
25. NOD2 gene variant is a risk factor for postoperative complications in patients with Crohn's disease: A genetic association study
26. Activation of Nod2 signalling upon Norovirus infection enhances antiviral immunity and susceptibility to colitis
27. Spatially-resolved metabolomic identifies colibactin-specific principles of reprogrammed lipid metabolism to promote cancer progression
28. Tirap controls Mycobacterium tuberculosis phagosomal acidification
29. Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment
30. Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments
31. Microbe-mediated intestinal NOD2 stimulation improves linear growth of undernourished infant mice
32. The NLRP6 protein is very faintly expressed in several normal and cancerous epithelial cells and may be confused with an unrelated protein
33. CARD8 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease
34. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
35. IL17 and/or IL22 as Potential Target(s) for Crohn’s Disease
36. The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut
37. Monocyte intrinsic NOD2 signalling inhibits pathogenic macrophage differentiation and its loss in inflammatory macrophages improves intestinal inflammation
38. IL-17/23, potential targets for Crohn’s disease
39. NLRs: a Cytosolic Armory of Microbial Sensors Linked to Human Diseases
40. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens
41. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
42. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis
43. NOD-like receptors in asthma
44. A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway
45. Enterocyte loss of polarity and gut wound healing rely upon the F-actin—severing function of villin
46. Hemidesmosome integrity protects the colon against colitis and colorectal cancer
47. Effects of enteral polymeric diet on gut microbiota in children with Crohnʼs disease
48. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis.
49. Diurnal Interplay between Epithelium Physiology and Gut Microbiota as a Metronome for Orchestrating Immune and Metabolic Homeostasis
50. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.